Previous Close | 744.50 |
Open | 744.70 |
Bid | 736.89 x 100 |
Ask | 738.93 x 100 |
Day's Range | 737.63 - 751.40 |
52 Week Range | 735.95 - 1,211.20 |
Volume | |
Avg. Volume | 714,178 |
Market Cap | 81.099B |
Beta (5Y Monthly) | 0.14 |
PE Ratio (TTM) | 18.25 |
EPS (TTM) | 40.44 |
Earnings Date | Jan 31, 2025 - Feb 04, 2025 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1,078.11 |
We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other genomics stocks. Genomics is the study of genes and how they function. Many rapidly growing companies are emerging in the genomics […]
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund was down 3.72% for the quarter vs. +2.54% for the MSCI ACWI (in $A). It was down 5.59% in September vs. -0.35% for the index. The market rose in the […]